Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.
出版信息
J Clin Pathol. 1990 Mar;43(3):177-83. doi: 10.1136/jcp.43.3.177.
Abstract
摘要
相似文献
1
Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.口服抗凝治疗指南：第二版。英国血液学学会。英国血液学标准委员会。止血与血栓形成特别工作组。
J Clin Pathol. 1990 Mar;43(3):177-83. doi: 10.1136/jcp.43.3.177.
2
Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.溶栓治疗使用指南。英国血液学标准委员会止血与血栓形成特别工作组。
Blood Coagul Fibrinolysis. 1995 May;6(3):273-85.
3
4
Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.新型口服抗凝药物治疗患者的选择与评估：国际血栓与止血学会科学与标准化委员会抗凝控制小组委员会的建议
J Thromb Haemost. 2013 Jan;11(1):177-9. doi: 10.1111/jth.12038.
5
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.口服达比加群或利伐沙班患者的常规凝血筛查及抗凝强度评估：英国血液学标准委员会的指南
Br J Haematol. 2012 Nov;159(4):427-9. doi: 10.1111/bjh.12052. Epub 2012 Sep 13.
6
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.肝素治疗实验室监测的局限性。科学与标准化委员会通讯：代表国际血栓与止血学会科学与标准化委员会抗凝控制小组委员会。
Thromb Haemost. 2002 Jan;87(1):163-4.
7
Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.稀释蝰蛇毒时间试验在服用华法林患者中的临床应用价值。
Int J Hematol. 2017 Aug;106(2):206-211. doi: 10.1007/s12185-017-2228-y. Epub 2017 Apr 7.
8
Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.非香豆素类抗凝剂的测定及其对止血检测的影响：英国血液学标准委员会指南
Br J Haematol. 2014 Sep;166(6):830-41. doi: 10.1111/bjh.12975. Epub 2014 Jun 14.
9
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology.口服抗凝治疗审计。英国血液学学会BCSH止血与血栓形成特别工作组。
J Clin Pathol. 1993 Dec;46(12):1069-70. doi: 10.1136/jcp.46.12.1069.
10
Concerns for Bleeding in the Elderly with the Use of Direct Oral Anticoagulants.
Consult Pharm. 2018 May 1;33(5):262-267. doi: 10.4140/TCP.n.2018.262..
引用本文的文献
1
The Utilization of Antithrombotic Therapy in Older Patients in Aged Care Facilities With Atrial Fibrillation.老年护理机构中患有心房颤动的老年患者抗血栓治疗的应用
Clin Appl Thromb Hemost. 2018 Apr;24(3):519-524. doi: 10.1177/1076029616686421. Epub 2017 Jan 10.
2
The Safety of Laparoscopic Sleeve Gastrectomy in Patients Receiving Chronic Anticoagulation Therapy: A Case-Matched Study.接受慢性抗凝治疗患者行腹腔镜袖状胃切除术的安全性：一项病例对照研究。
Obes Surg. 2015 Sep;25(9):1686-92. doi: 10.1007/s11695-015-1590-1.
3
Evaluation of coagulant activity after mechanical heart valve replacement.
J Artif Organs. 2006;9(3):161-4. doi: 10.1007/s10047-006-0339-y.
4
Self management of oral anticoagulation: randomised trial.口服抗凝剂的自我管理：随机试验。
BMJ. 2005 Nov 5;331(7524):1057. doi: 10.1136/bmj.38618.580903.AE. Epub 2005 Oct 10.
5
Primary care anticoagulant management using near patient testing.使用即时检验进行基层医疗抗凝管理。
Ir J Med Sci. 2003 Jan-Mar;172(1):30-2. doi: 10.1007/BF02914783.
6
Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.华法林治疗起始阶段国际标准化比值及维持剂量的预测
Br J Clin Pharmacol. 1999 Jul;48(1):63-70. doi: 10.1046/j.1365-2125.1999.00967.x.
7
Suspected acute pulmonary embolism: a practical approach. British Thoracic Society, Standards of Care Committee.疑似急性肺栓塞：实用方法。英国胸科学会，护理标准委员会。
Thorax. 1997 Oct;52 Suppl 4(Suppl 4):S1-24.
8
Drug treatment associated with heart valve replacement.与心脏瓣膜置换相关的药物治疗。
Drugs. 1995 Jun;49(6):897-911. doi: 10.2165/00003495-199549060-00004.
9
Therapeutic target values in oral anticoagulation--justification of Dutch policy and a warning against the so-called moderate-intensity regimens.口服抗凝治疗的目标值——荷兰政策的依据及对所谓中等强度治疗方案的警示
Ann Hematol. 1992 Feb;64(2):60-5. doi: 10.1007/BF01715346.
10
Therapeutic ranges for oral anticoagulation in different thromboembolic disorders.不同血栓栓塞性疾病口服抗凝治疗的治疗范围。
Ann Hematol. 1992 Feb;64(2):52-9. doi: 10.1007/BF01715345.
本文引用的文献
1
Venous thrombosis and pulmonary embolism. Their prevention by oral anticoagulants.静脉血栓形成与肺栓塞。口服抗凝剂对其的预防。
Am J Med. 1962 Nov;33:703-16. doi: 10.1016/0002-9343(62)90248-6.
2
Calibration of reference thromboplastins and standardisation of the prothrombin time ratio.
Thromb Haemost. 1983 Jun 28;49(3):238-44.
3
Therapeutic control of anticoagulant treatment.抗凝治疗的治疗性控制
Br Med J (Clin Res Ed). 1982 Mar 6;284(6317):702-4. doi: 10.1136/bmj.284.6317.702.
4
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.不同强度的口服抗凝治疗在近端静脉血栓形成治疗中的应用
N Engl J Med. 1982 Dec 30;307(27):1676-81. doi: 10.1056/NEJM198212303072704.
5
Standardisation of oral anticoagulant treatment.口服抗凝治疗的标准化
Br Med J (Clin Res Ed). 1983 Oct 8;287(6398):1000-1. doi: 10.1136/bmj.287.6398.1000.
6
Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding.两步法华法林治疗。预防术后静脉血栓形成且无过度出血。
JAMA. 1983 Jan 21;249(3):374-8. doi: 10.1001/jama.249.3.374.
7
Thromboplastin and oral anticoagulant control.
Br J Haematol. 1987 May;66(1):1-4.
8
Survey of prothrombin time in National External Quality Assessment Scheme exercises (1980-87).国家外部质量评估计划活动（1980 - 1987年）中凝血酶原时间的调查
J Clin Pathol. 1988 Apr;41(4):361-4. doi: 10.1136/jcp.41.4.361.
9
Antithrombotic agents in coronary artery disease.
Chest. 1989 Feb;95(2 Suppl):52S-72S. doi: 10.1378/chest.95.2_supplement.52s.
10
Optimal therapeutic range for oral anticoagulants.
Chest. 1989 Feb;95(2 Suppl):5S-11S.
Zotero 插件